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Contact lens discomfort (CLD) is a frequently experiencedproblem, with most estimates suggesting that up to half of
contact lens wearers experience this problem with some
frequency or magnitude. This condition impacts millions of
contact lens wearers worldwide. Yet, there is a paucity of
consensus and standardization in the scientific and clinical
communities on the characterization of the condition, includ-
ing the definition, classification, epidemiology, pathophysiolo-
gy, diagnosis, management, influence of contact lens materials,
designs and care, and the proper design of clinical trials.
The Tear Film & Ocular Surface Society (TFOS), which is a
nonprofit organization, has conducted two prior international,
consensus building workshops, including the Dry Eye WorkShop
(DEWS; available in the public domain at http://www.tearfilm.
org/tearfilm-reports-dews-report.php) and the Meibomian Gland
Dysfunction Workshop (MGD; available in the public domain at
http://www.tearfilm.org/tearfilm-reports-mgdreport.php). To
that end, TFOS initiated the process of conducting a similar
workshop in January 2012—a process that took approximately
18 months to complete and included 79 experts in the field.
These experts participated in one or more topical subcommit-
tees, and were assigned with taking an evidence-based approach
at evaluating CLD. Eight topical subcommittees were formed,
with each generating a related report, all of which were
circulated for presentation, review, and input of the entire
workshop membership.
The entire workshop originally is being published in this
issue of IOVS, in English, with subsequent translations into
numerous other languages. All of this information is intended to
be available and accessible online, free of charge. This article is
intended to serve as an Executive Summary of the eight
subcommittee reports, and all information contained here was
abstracted from the full reports.
DEFINITION AND CLASSIFICATION OF CLD
While clinicians practicing in the area of contact lenses all are
familiar with CLD, a variety of terms and verbiage have been
used to describe this problem. Typically these patients present
with symptoms of ocular discomfort of some sort (e.g., dryness,
irritation, discomfort, fatigue, and so forth), and it is common
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that these symptoms usually increase over the day while the
patient is wearing the contact lenses. However, beyond this, no
standard definition has been agreed upon globally with
consensus as to what this problem is. As such, the definition
of ‘‘CLD’’ is the following:
Contact lens discomfort is a condition characterized by
episodic or persistent adverse ocular sensations related
to lens wear, either with or without visual disturbance,
resulting from reduced compatibility between the
contact lens and the ocular environment, which can
lead to decreased wearing time and discontinuation of
contact lens wear.
The CLD Workshop membership characterized each of the
terms in the definition, considering many other concepts in the
development of the final definition. The rationale for the
specific terminology included in the definition, and related
terminology, can be found detailed in this subcommittee
report. However, it is important to note that the CLD
Workshop recognizes that CLD occurs while a contact lens is
worn, and that the removal of contact lenses mitigates the
condition (in particular the adverse ocular sensations).
However, CLD is a condition that occurs after the initial
‘‘adaptation’’ period a neophyte goes through when first
adjusting to contact lens wear. Physical signs may, or may not,
be present in accompanying the adverse ocular sensations.
Moving forward, the condition should be recognized as noted
above, and the terms ‘‘contact lens dry eye’’ or ‘‘contact lens–
related dry eye’’ should not be used when talking about
contact lens discomfort. These terms should be reserved for an
individual who has a preexisting dry eye condition, which may
or may not be exaggerated when contact lenses are worn.
Contact lens dropout refers to discontinuation of contact lens
wear for a sustained period of time.
Classification of CLD was challenging, as classifying a
disease relates to the ability to categorize it based on
knowledge of the etiology. In addition, to our knowledge
there has not been a previous classification scheme, and an
understanding of etiologic factors has been identified in the
other subcommittee reports as significantly lacking for CLD.
The CLD Workshop felt that the two major categories of CLD
were the contact lens and the environment (Fig. 1). The
contact lens category was divided further into four subcatego-
ries: material, design, fit and wear, and lens care. The
environment category also was broken down further into four
subcategories: inherent patient factors, modifiable patient
factors, ocular environment, and external environment. Details
of each of these subcategories can be found within the
Definition and Classification Report.
Lastly, very little is agreed upon regarding the temporal
progression of CLD, as this relates to contact lens dropout (or
permanent cessation of contact lens wear). As such, the modes
of progression also are presented in Figure 1, showing the
temporal progression of CLD as patients begin to struggle,
which is followed by the adoption of management strategies
(e.g., reducing wearing time), and ultimately by contact lens
dropout.
EPIDEMIOLOGY OF CLD
The epidemiologic assessment of CLD faces many challenges,
not least of which is the accurate assessment of the frequency
of the condition. Since the first publication in 1960 linking
hygienic contact lens care and comfortable lens wear, the issue
of CLD remains a major reason for discontinuation of contact
lens wear. It is estimated that there currently are more than 140
million contact lens wearers worldwide. It is much more
difficult to estimate the number of individuals who previously
have worn contact lenses and then abandoned lens wear as a
result of CLD. Studies report that between 12% and 51% of lens
wearers ‘‘drop out’’ of contact lens wear, with CLD the primary
reason for discontinuation.
While there have been tremendous developments in lens
polymers, designs, replacement modalities, and care regimens
over the last 50 years, the challenge of preventing or managing
CLD still is a problem in clinical practice. A major deficiency in
the literature is the lack of information derived from contact
lenses that differ in only one parameter.
Our limited understanding of the etiology and correlation
between signs and symptoms makes it all the more difficult to
diagnose and manage CLD. The tools used to diagnose CLD and
the expectations of contact lens wearers continually change,
making it difficult to draw conclusions over time and to
compare results from multiple studies. There are few validated
instruments for assessing comfort in contact lens populations,
and these tend to produce data that are highly variable, as most
rely on a patient’s recall. In addition, the lack of postmarket
surveillance studies, which would address many of the issues
related to CLD in a longitudinal fashion, prevent drawing
meaningful conclusions regarding the impact of technological
advances on CLD. Future epidemiologic work designed to
clarify the natural occurrence and evolution of CLD in rural
and urban population settings, and in various countries and
races are very much needed to enrich our understanding of
CLD and associated risk factors.
As CLD is reported primarily by symptomatology as
opposed to the observation of signs, and while the precise
etiology of CLD is yet to be determined, the use of symptoms
as an outcome measure is appropriate, because it relates
directly to the patients’ experience with contact lenses, and
the motivation to seek and use treatment, regardless of the
presence of observable signs. The frequency and intensity with
which these symptoms are reported can be assessed with the
use of questionnaires. Further research and agreement of a
universal adoption of a single measure of CLD is needed. The
Contact Lens Dry Eye Questionnaire has been well received
and, perhaps, is the most likely candidate for widespread CLD
assessment.
CONTACT LENS MATERIALS, DESIGN, AND CARE
The influence of contact lens materials and designs, including
rigid and soft contact lenses in these aforementioned areas, has
been of significant controversy in terms of their association or
etiologic influence in CLD. Further, there also has been great
interest in the role of contact lens care solutions, regimen
practices in caring for contact lenses, and wearing schedule
differences in terms of their influence on CLD.
The vast majority of today’s market is made up of soft
contact lenses (~90%), while rigid lenses make up the
remainder of the market. Of soft lenses used, silicone hydrogel
lenses now make up the majority of the market share within
most major worldwide markets. Through the years, there has
been a question about the role of materials and designs on the
problem of CLD. This issue was first recognized in the peer
reviewed literature in the early 1970s for rigid lens materials
and in the 1980s for soft lens materials. Since that time,
practitioners and scientists have questioned the influence of
polymer chemistry, and various other material attributes that
can be measured and quantified. The attributes considered
have included the bulk (e.g., water content, dehydration,
ionicity, oxygen transmissibility, modulus, and mechanical
factors) and the surface (e.g., friction, wettability, surface
modification) of contact lens materials. To date, almost none of
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these attributes, with the possible exception of friction based
on early evidence, appears to be associated directly with CLD.
Studies evaluating these factors, however, can be difficult to
draw conclusions from in that they are confounded with
differing designs, lack of rigor, lack of consistent definitions
(e.g., of discomfort), and an inability to hold the design
constant when testing the influence of a material or its
attribute. Lastly, contact lens material chemistry also is known
to influence tear film component deposition (proteins and
lipid primarily), but the role of deposition in general is
equivocal, perhaps again due to difficulties and inconsistencies
in measurement and quantification of deposition.
Contact lenses vary in terms of their designs, and there has
been some notion that the design of a lens influences the on-
eye comfort during wearing. There is no question that the
design of contact lenses influences their ability to fit the ocular
surface properly, and this is influential in terms of overall
performance. For instance, for soft contact lenses, moderate
on-eye movement (with tear exchange) and corneal coverage
are recognized as being important, but its overall association
with CLD is not entirely clear. Likewise, in rigid lens fitting, the
influence of the eyelid–edge interaction is recognized as being
important in terms of patient comfort, but this relation again is
not entirely clear in terms of its overall association with CLD.
However, there is even less consensus when considering the
influence of various design attributes on CLD. That said, the
size, shape, and contour of lens edges appear to be some of the
most influential determinants of contact lens comfort for soft
and rigid contact lenses.
Lastly, contact lens care solutions, contact lens care
practices, and contact lens wear schedules certainly are of
interest in terms of understanding their role(s) in CLD. To date,
the peer-reviewed literature does not give a clear indication of
specific formulations or components that may be associated
either with increasing CLD or with improving contact lens
comfort. However, most practioners agree that regular contact
lens care by contact lens wearers, including rub, rinse, and
adequate soaking (disinfection and cleaning) are important in
the success of lens wear. Further, most agree that increasing
the frequency of replacement of soft contact lenses is ideal for
ocular health and potentially improving comfort, although it is
difficult to define the ideal replacement schedule. To our
knowledge, large-scale, well-controlled studies using contem-
porary devices have not been conducted to provide insight
into these issues.
NEUROBIOLOGY OF DISCOMFORT AND PAIN
Contact lenses interact with some of the most richly
innervated areas of the body, such as the cornea, lid margin,
and to a lesser extent the conjunctiva, and so it perhaps is not
surprising that the eye can detect and sometimes react to the
presence of the contact lens. The sensory (afferent) nerves
(i.e., those that react to ‘‘pain’’ stimuli), which are derived from
the ophthalmic and maxillary regions of the trigeminal
ganglion, give rise to numerous intraepithelial terminals, some
of which may extend to within a few micrometers of the ocular
surface. The sensory nerves of the cornea consist of polymodal
receptors (which can react to near-noxious or noxious
mechanical energy, heat, cooling, chemical irritants, and by a
large variety of inflammatory mediators), mechano-nociceptors
FIGURE 1. Classification of CLD.
Executive Summary IOVS j October 2013 j Vol. 54 j No. 11 j TFOS9
(which respond to mechanical forces of a magnitude close to
that required to damage corneal epithelial cells), and cold-
sensitive thermoreceptors (which react to temperature drops
produced by evaporation of tears at the corneal surface, or
application of cold and hyperosmolar solutions). Activation of
these nociceptors is via specific ion channels; however, there
appears to be no linear relationship between channel
activation and contact lens discomfort.
Postreceptor propagation of the sensory nerve signal travels
from the source through trigeminal ganglion to terminate in
multiple spatially discrete zones along the rostrocaudal axis of
the trigeminal brainstem sensory complex (TBSC) of the
central nervous system. In this region, sensory nerves
terminate mainly in the ventral aspect of the transition region
between caudal interpolaris of the spinal trigeminal nucleus
and caudalis of the same region (Vi/Vc) or at the spinomedul-
lary junction (Vc/C1). Evidence suggests that ocular sensory
neurons at Vi/Vc or Vc/C1 serve different functions in ocular
homeostasis and sensation. Drying or detection of cold at the
ocular surface stimulates the Vi/Vc region only. Transection of
the spinal trigeminal tract at Vi/Vc eliminates pain sensation
upon corneal stimulation, but a sense of corneal touch
remains. Pharmacologic blockade of only Vi/Vc prevents reflex
lacrimation evoked by chemical stimulation of the ocular
surface. The ascending projections from second-order ocular
neurons in the TBSC to higher brain centers are not well
known and no systematic mapping study has been reported,
even though the complex nature of many ocular perceptions,
such as dryness, grittiness, itch, irritation, and fatigue, suggests
interactions across multiple psychophysical channels that
require integration at higher brain centers.
Contact lens wear may, or may not, alter nerve fiber density,
tortuosity, branching, beading, thickness, or reflectivity. The
large changes in morphology of the subbasal nerve plexus in
the cornea during orthokeratology (OK) lens wear increase the
threshold to sensation. Changes in corneal sensitivity with
contact lens wear have been reported widely, but the
underlying mechanism is not known, and the outcomes of
studies may be very dependent on the type of instrument used
to test sensitivity. The fact that tactile/pneumatic stimulus of
the cornea after soft contact lens wear is reduced, but no
associated change occurs in symptoms of discomfort during
lens wear, suggests that the touch response in the cornea, and,
hence, propagation of the stimulus through Vc/C1, is not
associated with CLD. This then may implicate the cooling,
osmolality differences detected through the Vi/Vc region. An
alternate hypothesis, but not necessarily mutually exclusive, is
the possibility of mechanical stimulation of the nociceptors in
the lid wiper region of the eyelids. Stimulation of subacute
inflammation of the ocular surface during lens wear may occur,
and nerves can respond to the production of a variety of
inflammatory mediators, including cytokines and arachidonic
acid metabolites. The key neurotransmitters involved in the
transmission of ocular sensations in human cornea and
conjunctiva have been identified as substance P and calcitonin
gene-related peptide (CGRP). No change in tear levels of
substance P was found in a group of contact lens wearers
compared to nonwearers, which may indicate no role for
substance P in CLD. No reports on changes to CGRP were
found. Conversely, the neurotrophin nerve growth factor
(NGF) appears to be upregulated in CLD. As NGF is involved
in survival and maintenance of sympathetic and sensory
neurons, its upregulation suggests that nerves either are being
damaged (and so need extra NGF for repair) or being altered in
other ways during CLD.
Much more research needs to be performed to enable a
comprehensive outline of the neurobiology of CLD. Better
integration of the research from the peripheral and central
nervous system, with observations of nerve morphology/
structural changes, and the biochemistry of the system could
only be beneficial to our understanding of CLD. An important
first step would be to design experiments to determine which
tissue (e.g., corneal or lid margin) is the primary sensory
location of CLD.
CONTACT LENS INTERACTIONS WITH THE OCULAR
SURFACE AND ADNEXA
It would appear obvious that the interactions of a contact lens
with the ocular surface and tear film are critical in the
successful wear of the lens and the development of CLD. This
subcommittee investigated the impact of contact lenses on the
ocular surface and attempted to link these interactions to the
development of CLD. A thorough review of the literature
identified many dozens of ocular surface tissue alterations that
may occur as a result of lens wear. While many of these result
in frank pain (e.g., microbial keratitis), it was determined that
such obvious pathologic complications were not the remit of
this exercise and that the subcommittee would consider only
potential tissue alterations that were associated with CLD (as
defined above), and not pain that remained upon removal of
the lens.
The cornea serves as the major surface on which the lens
sits and could be a significant factor in CLD, particularly as it
relates to its neurobiology. However, morphologic and
apoptotic changes within the corneal epithelium have not
been linked to CLD, nor have any changes in corneal epithelial
barrier function. Despite many publications examining corneal
staining associated with CL wear, overall, there appears to be,
at best, a weak link between CLD and corneal staining, and it is
not a major factor for most CL wearers. No stromal (keratocyte
density, stromal opacities, stromal infiltrates, and stromal
neovascularization), endothelial, or limbal (redness or stem
cell deficiency) changes induced by lens wear were proven to
be associated with CLD. While hypoxia can be a complication
with many lens types or designs, no specific association with
any hypoxic changes or marker of hypoxia could be linked
directly to CLD.
The conjunctiva proved to be a tissue more closely linked to
the development of CLD. Bulbar conjunctival staining, typically
viewed using lissamine green, was found in some studies to be
associated with CLD, particularly soft lens edge-related
staining, and this may be related to lens edge design. While
edge design and modulus may be linked to the development of
conjunctival epithelial flaps, there appears to be no association
between this tissue change and CLD. Bulbar hyperemia was not
linked to CLD. Cytologic changes in the bulbar conjunctiva do
occur in some wearers with CLD, but the many months it takes
to reverse these changes obviously argues against a strong
association with CLD, as CLD is relieved rapidly by removal of
the lens from the eye.
The palpebral conjunctiva has an important role in
controlling the interaction with the ocular surface and lens.
Two specific issues potentially linked to CLD include
alterations to the meibomian glands and to the leading edge
of the palpebral conjunctiva as it moves across the lens surface
(the so-called ‘‘lid-wiper’’ zone). Contact lens wear does appear
to impact the function of the meibomian glands and reduced
meibomian gland function has been associated with contact
lens wear, but further studies are required for confirmation.
Alterations to the lid-wiper area are more common in contact
lens wearers who are symptomatic, and some studies have
related these tissue changes to CLD. However, further work is
necessary to investigate whether lid wiper epitheliopathy
(LWE) is caused by specific properties of the lens material,
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whether upper LWE is more or less relevant than lower LWE,
whether making changes to contact lens properties, rewetting
drops, or solutions can influence positively the degree of LWE,
and to what extent modification of LWE will alleviate CLD.
Finally, the lid margin is colonized more frequently with
microbes than the conjunctiva, but the frequency of isolation
varies between wearers. The role of lid microbiota has been
studied only superficially during CLD and this also is an area
worthy of future study, given that microbial toxins can impact
ocular comfort.
In conclusion, some evidence is available to suggest a link
between conjunctival and lid changes with CLD, with the
strongest evidence being that related to meibomian gland and
LWE changes. No convincing evidence of a link to CLD was
unearthed with respect to any of the other forms of CL-
associated tissue changes. Future studies would benefit from
longitudinal designs that attempt to understand what patho-
physiologic changes occur in new wearers over time, and
whether changes to lens materials, design, fit, or other factors
impact these tissue changes. Studies also should examine
whether the magnitude or timing of such changes can be
related to the magnitude and timing of CLD.
CONTACT LENS INTERACTIONS WITH THE TEAR FILM
In evaluating contact lens interactions with the tear film and
how those interactions might result in discomfort, the
workshop considered the biophysical and the biochemical
effects of contact lens wear on the tear film and their influence
on discomfort.
The physical presence of a contact lens in situ divides the
tear film into a pre- and postlens tear film, creating new
interfaces with the ocular environment. Tear film changes
occur upon lens application and during subsequent wear. In
addition, biochemical differences are likely to exist between
the pre- and postlens tear film layers. Partitioning of the tear
film upon contact lens application and wear causes a series of
compositional changes that result in a less stable tear film on
the front surface of the lens and less well-defined changes to
the postlens tear film layer. The resulting prelens tear film has
reduced lipid layer thickness, reduced tear volume, and
increased evaporation rate compared to the normal tear film.
While the direct impact of these tear properties on discomfort
has not been elucidated fully, the evidence to date specifically
suggests that decreased tear film stability, increased tear
evaporation, reduced tear film turnover, and tear ferning are
associated with CLD. Further evidence is needed to support
the associations between tear volume, surface tension,
osmolarity, pH, and ocular surface temperature and CLD.
With respect to biochemical changes in tear film composi-
tion associated with contact lens wear, there appears to be no
relationship between total protein, lactoferrin, and lysozyme
with CLD. Current evidence suggests that levels of tear
lipocalin-1, levels and activity of sPLA2, and levels of degraded
lipids may be increased, and phospholipids decreased in CLD,
which may be consistent with biochemical and functional
changes in the tear lipid layer. Certain polar lipids, specifically
the (O-acetyl)-omega-hydroxy fatty acids and their esters, have
been associated with symptom reporting and may be
important in CLD. Further evidence is needed to establish
links between MUC5AC and other changes in the tear
proteome with CLD. Given the potential evidence for frictional
wear and lid wiper epitheliopathy in the pathophysiology of
CLD, it may be expected that tissue and tear proteases, and
inflammatory mediators would be increased in the tear film;
however, such changes have not yet been demonstrated
consistently.
There are significant gaps in our understanding of the
extent to which tear film changes in contact lens wear are
responsible for CLD. There is good evidence for associations
between changes in tear lipids likely in the prelens tear film
and CLD, although it is not clear if these changes are causal, or
that they are present before contact lens wear. To understand
these relationships better, it is important to use the definition
of CLD as defined herein in future research and to study
relevant subject groups using an appropriate study design. The
lack of evidence for the postlens tear film in CLD likely relates
to the current difficulties in evaluating this layer, in addition to
the fact that this layer is relatively stagnant, as it largely is
trapped and stagnant behind the contact lens.
Evidence also suggests that the parameters of the prelens
tear film are interrelated and, therefore, it is difficult to identify
a single component as being responsible for CLD. Tear film
stability (via evaporation), however, is recognized as a key
factor in CLD, and it appears to be a consequence of multiple
tear film characteristics and their interactions. Given the
relevance of prelens tear film stability in CLD, future research
should focus on the development of novel materials or surface
treatments to resist tear evaporation during wear, and on the
development of wetting agents in care products to promote
long-term contact lens wettability.
TRIAL DESIGN AND OUTCOMES
Design of clinical trials to determine the possible causes of
CLD, for the most part, have not been optimal and numbers of
participants in the trials generally small. Surprisingly, given the
strong association of CLD with discontinuation of contact lens
wear, the design of clinical trials has tended to focus on
performance of certain contact lenses or lens care solutions,
rather than the specific nature and etiology of contact lens
discomfort. This may be due to the majority being industry-
sponsored clinical trials.
Most clinical trials have evaluated the role of lens type
(material differences), use of care systems, and effect of lens
fitting, but they have been limited in their ability to isolate one
factor from others. A significant limitation has been the lack of
a consensus-based definition of CLD to date. Other limitations
include lack of control of confounding variables or use of
proper controls. An example of this is the problem often found
when reports have been published on the results of changing
wearers from their habitual lens of choice to a new (sometimes
experimental) lens. Without appropriate masking and controls
(for example, not only changing to the new lens type, but
refitting a portion of subjects with or crossing over the subjects
into their habitual lenses once masked), results tend to suffer
from inherent bias.
This subcommittee report details many types of bias that
should be considered in future work in this area. Further,
prospective trial designs with randomization of subjects and
double masking is optimal. Consideration of run-in and wash-
out periods are important to avoid memory bias or changes
that may occur to physiology during wear of lenses.
Appropriate entry criteria and adequate sample size determi-
nations a priori are critical.
Finally, it was determined that certain factors from clinical
trials, at least potentially, had been associated with CLD. These
included lid wiper epitheliopathy, tear film stability/volume,
and lid parallel conjunctival folds. It was recommended that
further appropriately designed clinical trials be performed to
assess these factors (and others). Although no single outcome
parameter of contact lenses was found to be validated fully, it
was concluded that the Contact Lens Dry Eye Questionnaire
currently was the most appropriate subjective outcome for
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FIGURE 2. Summary of the management strategies for CLD.
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CLD. An even more reliable and sensitive outcome parameter is
needed for future work in this area.
MANAGEMENT AND THERAPY OF CLD
The condition of CLD is a considerable management and
therapy challenge in clinical practice. While the causes of the
short-term discomfort following difficulty with lens insertion
generally are understood and appropriate remedies are
straightforward, symptoms of discomfort and dryness that
persist and increase toward the end of the day pose a more
intractable problem. Managing wearers in these circumstances
requires careful, individual assessment to eliminate concurrent
conditions that may confuse the clinical picture, followed by a
determination of the most likely cause or causes, and
identification of corresponding treatment strategies (Fig. 2).
The aim is to ensure that the contact lens is in a clinically
acceptable ocular environment without obvious lens deficits of
either a physical or behavioral nature.
A careful history of the presenting problem and the general
status of the patient is a critical first step in the management
process for CLD. Key elements in the evaluation include the
age and sex of the wearer, timing and onset of symptoms, type
of lens and lens material, care systems, lens replacement
schedules, use of additional wetting agents, wear times and
patterns, compliance and adherence to instructions, the
occupational environment, coexisting disease, and current
medications.
It is important to recognize that the symptom ‘‘discomfort’’
is relatively nonspecific, as discomfort can result from many
sources other than the contact lens. Coexisting pathologies
that may be responsible for the patient’s symptoms, such as
ocular medicamentosa, systemic disease (autoimmune diseases
and atopic disease), eyelid disease (blepharitis and anatomic
abnormalities), tear film abnormalities, and conjunctival and
corneal diseases, are important to identify and treat before
focusing on the contact lens as the source of discomfort.
After noncontact lens causes of CLD have been identified
and treated, the focus is on the contact lens and care system.
Contact lens defects, such as edge chips and tears, deposits,
and nonwetting surfaces, are typical causes of contact lens–
related problems. Contact lens design properties (such as edge
design), material properties, and on-eye fit, also are issues that
must be considered. Care solutions and their components or
improper care regimens also may at times contribute to CLD,
and the benefits of daily disposable lenses may, in part, be due
to elimination of these factors. However, the solution in the
blister pack of disposable lenses also can be a source of CLD,
particularly on application of contact lenses.
Frequent and appropriately-timed replacement of contact
lenses may reduce or eliminate deposit formation. Switching
to a different care system may have some effect on deposit
formation. Although changing lens material may be helpful, it
is difficult to separate material from design and surface effects
as sources of CLD.
Fitting with steeper base curves, using larger diameter
lenses, alternating the back lens surface shape, and using
lenses with a thinner center thickness may improve CLD.
However, it is difficult to manipulate lens parameters in
isolation from each other, as altering one parameter may
influence the other parameters.
The use of topical artificial tears and wetting agents, oral
essential fatty acids (FA), punctal occlusion, and topical
medications (e.g., azithromycin, cyclosporine A), along with
avoiding adverse environments (e.g., aircraft cabins) and
altering blinking behavior, all have been used in treatment of
patients with dry eye and may be useful adjuncts in reducing
CLD, although these require more substantial evidence in the
future relative to their use (or lack thereof).
All these tactics may have limited effect on CLD and
incremental improvements in CLD may be all that can be
expected reasonably from any single intervention. The addition
of treatments in a stepwise manner may be required to provide
the maximum possible relief. Unfortunately, given the current
state of knowledge of CLD, some patients will have residual
levels of CLD that are sufficiently bothersome that it causes
them to discontinue contact lens wear.
CONCLUSIONS
The TFOS International Workshop on CLD has addressed
many areas of interest within the contact lens community as
they relate to characterizing the ever-persistent problem of
CLD. As noted, this international group of experts provided a
framework that future studies and clinical activities can build
upon when working in this area. It is critically important that
the definition of CLD (as noted above) be applied in trials and
studies that address CLD, including validated outcomes, such
that there is consistency across research activities. Likewise,
prospective natural history studies, which have not been
performed to date, will help us better determine the
incidence and risk factors for this condition, including factors
that may relate to the patient or contact lenses in some way
(e.g., material characteristics, designs, care system character-
istics, care regimens). Etiologic considerations, including
interactions with the ocular surface and tear film, need better
models that will allow improved preclinical insight, and
ultimately bench to the clinic translation in the development
of novel products. Lastly, clinicians must be diligent in
working with patients with CLD. It is important that the
process of prevention and management of CLD starts early,
perhaps even before the onset of symptoms, to improve the
long-term prognosis of successful, safe, and comfortable
contact lens wear.
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